Prof. Dr. rer. nat. habil. Charlotte Kloft
Head of Department Clinical Pharmacy & Biochemistry
Institute of Pharmacy
Freie Universität Berlin
Professor
Head of Department Clinical Pharmacy & Biochemistry and Managing Director of the Institute Vice Dean of Research at BCP Faculty
Address
Freie Universität Berlin
Institute of Pharmacy
Kelchstr. 31
Room 225
12169 Berlin
Institute of Pharmacy
Kelchstr. 31
Room 225
12169 Berlin
Office
Telephone
Fax
+49(0)30 838 450656
Email
charlotte.kloft[at]fu-berlin.de
Office hours
for student consultation
Fri 12:30 - 1:30 p.m. (by appointment)
Curriculum Vitae
Present and previous positions
| Since 2011 | ‘Universitaetsprofessorin’ (Full Professor) and Head of Department of Clinical Pharmacy & Biochemistry at the Freie Universität Berlin |
| 2005-2011 | ‘Universitaetsprofessorin’ (Full Professor) and Head of Department of Clinical Pharmacy at the Martin-Luther-Universitaet Halle-Wittenberg |
| 1999-2005 | ‘Oberassistentin’ (Associate Professor)/’Wissenschaftliche Assistentin’ (Assistant Professor) at the Institute of Pharmacy, Freie Universität Berlin |
| 1997-1999 | Study manager, Dept. of Drug Metabolism/Pharmacokinetics, Clinical Pharmacokinetics, Hoechst Marion Roussel (today: Sanofi), Frankfurt/Main |
| 1993-1997 | ’Wissenschaftliche Mitarbeiterin’ (Graduate student) at the Institute of Pharmacy, Freie Universität Berlin |
Academic education; academic and professional degrees/qualifications
| Since 2012 | Permission for working with pathogenic microorganisms in accordance with § 44 ff IfSG (German Protection against Infection Act; “Infektionsschutzgesetz”) Certified laboratories: Biosafety level 2, defined in EU directive (Council Directive 90/679/EEC, 26 November 1990) |
| 2003 | Habilitation and venia legendi in Clinical Pharmacy, Freie Universität Berlin Title: Rationale dosing strategies based on pharmacokinetic-pharmacodynamic models in the treatment of cancer |
| 1997 | ’Dr. rer. nat. (summa cum laude)’ (PhD with highest honours) at the Faculty of Pharmacy, Freie Universität Berlin (Supervisors: Prof. Dr. U. Jaehde, Prof. Dr. Dr. Dr. h.c. W. Schunack) Title: Clinical pharmacokinetic and pharmacodynamic investigations for dose optimisation of platinum complexes |
| 1992 | Registered Pharmacist |
| 1991-1992 | Internship at SANDOZ (today Novartis), Basel, Switzerland, community pharmacy |
| 1987-1991 | Undergraduate studies of Pharmacy at the Johannes Gutenberg-Universität, Mainz |
Professional activities
| Since 2022 | Project Investigator (PI) in the project GlobalResist |
| Since 2021 | Project Coordinator of the project On-Target |
| Since 2020 | Work-Package-Leader, Principal Investigator (PI) and member of the Steering Committee in EU Horizon2020-Projekt “FAIR” |
| Since 2008 | Chair of the interdisciplinary Structured Graduate Research Training Program PharMetrX "Pharmacometrics and Computational Disease Modelling" (together with Prof. Dr. Wilhelm Huisinga) |
| 2016-2021 | Principal Investigator and member of the Steering Committee in the research consortium “ABIMMUNE” within the Joint Programming Initiative on Antimicrobial Resistance’, (BMBF Funding No.: 031L0097) |
| 2016-2021 |
Principal Investigator and member of the Executive Board Leader in the research consortium “COMBINATORIALS” within the Joint Programming Initiative on Antimicrobial Resistance (BMBF Funding No.: 031L0098B) |
| 2014-2018 | Principle Investigator (PI) in the TAIN project |
| 2011-2016 | Work Package Leader in EU Project “DDMoRe“ of the Innovative Medicines Initiative –Joint Undertaking |
| 2004, 2002 | Fellow with Prof. M.O. Karlsson, Uppsala University, Sweden |
| Since 2002 | Member of Editorial Boards and Referee of various international, peer-reviewed journals Guest Editor/Associate Editor: European Journal of Pharmaceutical Sciences (Guest Editor for Special Issue: Systems Pharmacology, 2015/2016) |
| Since 2002 | Scientific consultant for pharmaceutical companies |
| 1990 | Fellow with Prof. H. Derendorf, University of Florida, US |
Awards
amongst others
| Since 2000 | "Academic Center of Excellence" or follow-up programs (Pharsight today Certara, US) |
| 2002 | Habilitation grant of the Dr. August and Dr. Anni Lesmueller-foundation |
| 1998 | Ernst-Reuter-Preis 1998 of the Ernst-Reuter-Society of the Freie Universität Berlin |
| 1998 | Joachim-Tiburtius-Award 1998 of the Senate of Berlin |
| 1997 | Young Investigator Award 1997 of the European Organisation for Research and Treatment of Cancer - Pharmacology and Molecular Mechanism (EORTC-PAMM) |
Professional positions and memberships
amongst others
| Since 2023 | Member of the Scientific Board of the Frankfurt Foundation Quality of Medicines |
| Since 2017 | Chairperson of the Central European Society for Anticancer Drug Research (CESAR) – Pharmacometrics; 2013-2017 Vice Chairperson of CESAR - APOH |
| Since 2016 | Member of the Scientific Board of the German Pharmaceutical Society (DPhG) |
| Since 2014 | President of the German Pharmaceutical Society (DPhG), section Berlin-Brandenburg, and Member of the executive committee of DPhG |
| Since 2013 |
Member of the Drug Commission of German Pharmacists (Arzneimittelkommission der Deutschen Apotheker, AMK) |
| Since 2012 | Deputy Member of the Steering Committee (Ständige Kommission) of the Dahlem Research School, DRS |
| Since 2011 | Member of the Scientific Organising Committee of the PK/PD Expert Meeting (PK/PD-Expertentreffen) |
| Since 2009 | Member of the International Scientific Advisory Board of the ‘Internat. Symposium on Measurement and kinetics of in vivo drug effects’/since 2014: ‘Internat. Symposium on Pharmacokinetics, Pharmacodynamics and Systems Pharmacology’ in Noordwijkerhout, NL/ since 2020 ‘Quantitative Systems Pharmacolocy Conference’ in Leiden, NL |
| Since 2006 | Scientific Board member of the ’Deutsche Arzneibuch Kommission’ (German Pharmacopoeia) at the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM, Federal Institute for Drugs and Medical Devices) |
| Since 2006 | Scientific Board member of the ’Foerderinitiative Pharmazeutische Betreuung’ |
| Since 2002 | Member of the Scientific Organising Committee of the Population Approach Group Europe (PAGE); and Chief Organiser of the Annual Meeting PAGE 2010 in Berlin (600 participants) |
| 2012-2019 | Member of the Coordination Group of the Focus Area ’DynAge‘ (Disease in Human Aging) at the Freie Universität Berlin (www.fu-berlin.de/dynage) |
| 2005-2009 | Member of the European Federation of Pharmaceutical Sciences (EUFEPS) PharmSciFair 2009 Planning Team |
| 2003-2006 | Vice president of the Working Party Clinical Pharmacy of the German Pharmaceutical Society (DPhG) |
Academic self-government
amongst others
| Since 2023 |
Vice Dean of Research, Department of Biology, Chemistry, Pharmacy of FU Berlin |
| 2019-2023 |
Executive Director of the Institute of Pharmacy of FU Berlin |
| 2013-2019 |
Vice Director of the Institute of Pharmacy of FU Berlin |
| Since 2017 |
Deputy member of the Department Council Biology, Chemistry, Pharmacy of FU Berlin |
| Since 2013 |
Member of the Board of the Institute, Member of the Examination Committee of Institute, Member of the Education Commission of the Faculty of Biology, Chemistry, Pharmacy - AK Pharmacy (since 2023: representative), Freie Universität Berlin |
| Since 2012 | Member of the Doctoral Board at the Faculty of Biology, Chemistry, Pharmacy, Freie Universität Berlin |
| Since 2011 | Member of the Selection Committee of the "Deutschlandstipendium" (Scholarships) at the Freie Universität Berlin |
| 2010-2011 | Managing Director of the Institute Division Pharmaceutical Chemistry and Clinical Pharmacy at the Martin-Luther-Universität Halle-Wittenberg |
| 2006-2011 | Member of the Board of the Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg |
see here